Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Resistance to First-Line Drugs in Clinical Isolates of Mycobacterium Tuberculosis in Isfahan Publisher



Farzaneh S1 ; Norouzi F2 ; Fazeli H1 ; Moghim S1 ; Esfahani BN1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Microbiology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran

Source: Journal of Isfahan Medical School Published:2022


Abstract

Background: Tuberculosis (TB) remains a serious public health problem worldwide, causing millions of deaths annually. It is estimated that one-third of the world population is infected with latent TB. Drug-resistant TB is considered a major and growing global threat. In this study, we aimed to indicate the drug-susceptibility of Mycobacterium tuberculosis isolates from patients, presented to Mollahadi Sabzevari Tuberculosis Center in Isfahan, Iran to the first-line drugs. Methods: In this study, Mycobacterium tuberculosis was isolated from 438 patients with pulmonary tuberculosis referred to the Regional Reference Laboratory of tuberculosis in Isfahan province during 2017-2019, 33 resistant isolates were studied. Drug susceptibility testing to first-line drugs was performed by proportion method, and the H37Rv reference strain sensitive to all drugs was used for quality control. Findings: Out of 438 isolates, 20 isolates (37.7%) were drug-sensitive and 33 isolates (62.3%) were resistant to the first-line drug by phenotypic method, which was isoniazid (INH) 22 isolates (66.7%), rifampin (RIF) 18 isolates (54.5%), ethambutol (EMB) 4 isolates (12.1%) and pyrazinamide (PZA) 5 isolates (15.2%) respectively. Also, 10 isolates (30.3%) were multidrug-resistant tuberculosis (MDR-TB). Conclusion: The pattern of drug resistance in Mycobacterium tuberculosis is different in each region and in the Isfahan region due to the increasing drug resistance of tuberculosis. Further research is needed to determine the drug resistance of Mycobacterium tuberculosis. © 2022 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Experts (# of related papers)
Other Related Docs
24. Tuberculosis Program Evaluation in Isfahan 1 District, Journal of Isfahan Medical School (2010)
36. Mycobacterium Gordonae Pulmonary Infection With Clinical Manifestations Similar to Tuberculosis, Scientific Journal of Kurdistan University of Medical Sciences (2018)